We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among ST. JUDE MEDICAL, INC., ASTEROID SUBSIDIARY CORPORATION and AGA MEDICAL HOLDINGS, INC. Dated as of October 15, 2010Merger Agreement • October 18th, 2010 • AGA Medical Holdings, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledOctober 18th, 2010 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this "Agreement"), dated as of October 15, 2010, between St. Jude Medical, Inc., a Minnesota corporation ("Parent"), Asteroid Subsidiary Corporation, a Delaware corporation and an indirect wholly owned Subsidiary of Parent ("Merger Sub") and AGA Medical Holdings, Inc., a Delaware corporation (the "Company").
AGREEMENT AND PLAN OF MERGER by and among JOHNSON & JOHNSON, BINDER MERGER SUB, INC., and OMRIX BIOPHARMACEUTICALS, INC. November 23, 2008Merger Agreement • November 25th, 2008 • Omrix Biopharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 25th, 2008 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER, dated as of November 23, 2008 (this “Agreement”), by and among Omrix Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), Johnson & Johnson, a New Jersey corporation (“Parent”), and Binder Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Sub”).
AGREEMENT AND PLAN OF MERGER among ABBOTT LABORATORIES, S&G NUTRITIONALS, INC. and KOS PHARMACEUTICALS, INC. Dated as of November 5, 2006Merger Agreement • November 9th, 2006 • Abbott Laboratories • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 9th, 2006 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER, dated as of November 5, 2006 (this “Agreement”) among ABBOTT LABORATORIES, an Illinois corporation (“Parent”), S&G Nutritionals, Inc., a Delaware corporation and a direct wholly-owned Subsidiary of Parent (“Merger Sub”), and KOS PHARMACEUTICALS, INC., a Florida corporation (the “Company”).